Cambridge Healthtech Institute’s 28th Annual

Engineering Antibodies

Innovative Engineering Strategies to Enable Next Generation Therapeutics

May 11-12, 2027

The 2027 PEGS Boston Engineering Antibodies conference offers a program focusing on the most vexing technical problems now defining antibody drug development. Sessions cover the growing toolkit for reaching difficult targets and crossing biological barriers, from brain delivery shuttles to receptor agonism and tumor-restricted activation. Speakers will address how protein engineers are tuning antibody format, sugar chemistry, and half-life to meet specific clinical needs, alongside cytokine-based immune modulation, targeted protein degradation, and alternative scaffolds such as nanobodies and DARPins. The program also includes a look at AI and machine learning use cases across these disciplines.

Coverage will include, but is not limited to:

  • Antibody-Enabled Structural Biology
  • Antibody-Enabled Targeted Protein Degradation
  • Blood-Brain Barrier and CNS Delivery Shuttles
  • Conditional, Masked, and Tumor-Selective Antibody Activation
  • Cytokine and Immune-Modulator Engineering
  • Engineering for Challenging Target Classes
  • Engineering for Receptor Agonism
  • Fc Engineering, Half-Life Extension, and PK Optimization
  • Glycoengineering and Effector-Function Tuning
  • pH-Dependent, Recycling, and Sweeping Engineering
  • Small-Domain and Alternative Scaffold Engineering
  • Use Cases of AI/ML in Biologics Engineering

The deadline for priority consideration is October 23, 2026.

All proposals are subject to review by session chairpersons and/or the Scientific Advisory Committee to ensure the overall quality of the conference program. Additionally, as per Cambridge Healthtech Institute’s policy, a select number of vendors and consultants who provide products and services will be offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.

Opportunities for Participation:


For more details on the conference, please contact:
Kent Simmons
Senior Conference Director
Cambridge Healthtech Institute
Phone: 207-329-2964
Email: ksimmons@healthtech.com

For sponsorship information, please contact:

Companies A-K
Jason Gerardi
Sr. Manager, Business Development
Cambridge Healthtech Institute
Phone: 781-972-5452
Email: jgerardi@healthtech.com

Companies L-Z
Ashley Parsons
Manager, Business Development
Cambridge Healthtech Institute
Phone: 781-972-1340
Email: ashleyparsons@healthtech.com


Register

View By:


Premier Sponsors

Biointron_new       Kactus